MK-8723
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-8723, covering 2017-03-21 to 2017-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001) [Phase 1]